Latest Articles

Publication Date
Emma Barnett: I was told endometriosis is experienced by ‘very ambitious women’ - The Independent

Emma Barnett: I was told endometriosis is experienced by ‘very ambitious women’ The Independent

Published: June 1, 2026, 7:27 a.m.
Challenges in treating advanced endometriosis highlighted - MSN

Challenges in treating advanced endometriosis highlighted MSN

Published: June 1, 2026, 7:03 a.m.
Expanded Same Day Surgeries For Additional Procedures - Mirage News

Expanded Same Day Surgeries For Additional Procedures Mirage News

Published: May 31, 2026, 11:22 p.m.
Challenges in treating advanced endometriosis highlighted - newsdrum.in

Challenges in treating advanced endometriosis highlighted newsdrum.in

Published: May 31, 2026, 3:05 p.m.
Challenges in treating advanced endometriosis highlighted - ThePrint

Challenges in treating advanced endometriosis highlighted ThePrint

Published: May 31, 2026, 2:49 p.m.
Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients - Cancer Therapy Advisor

Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients Cancer Therapy Advisor

Published: May 30, 2026, 4 a.m.
Pembrolizumab Plus Chemotherapy Shows Sustained Survival in Advanced EC - CancerNetwork

Pembrolizumab Plus Chemotherapy Shows Sustained Survival in Advanced EC CancerNetwork

Published: May 30, 2026, 12:40 a.m.
Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer - OncLive

Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer OncLive

Published: May 29, 2026, 11:57 p.m.
Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer - Targeted Oncology

Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer Targeted Oncology

Published: May 29, 2026, 10:11 p.m.
Dostarlimab Plus Chemotherapy Demonstrates Sustained Disease Control in dMMR/MSI-H Advanced Endometrial Cancer - HMP Global Learning Network

Dostarlimab Plus Chemotherapy Demonstrates Sustained Disease Control in dMMR/MSI-H Advanced Endometrial Cancer HMP Global Learning Network

Published: May 26, 2026, 4:46 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!